- Clinical Trials
- March 2025
- 52 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Clinical Trials
- March 2025
- 289 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Clinical Trials
- March 2025
- 1657 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Clinical Trials
- March 2025
- 191 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Report
- March 2025
- 18 Pages
Global
From €13324EUR$14,995USD£11,537GBP
- Report
- March 2025
- 118 Pages
Global
From €13324EUR$14,995USD£11,537GBP
- Report
- March 2025
- 81 Pages
Global
From €8881EUR$9,995USD£7,690GBP
- Report
- February 2025
- 70 Pages
Global
From €3105EUR$3,495USD£2,689GBP
- Clinical Trials
- February 2025
- 107 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Clinical Trials
- February 2025
- 254 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Clinical Trials
- February 2025
- 104 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Clinical Trials
- February 2025
- 390 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Clinical Trials
- February 2025
- 819 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Clinical Trials
- February 2025
- 627 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Report
- February 2025
- 135 Pages
Global
From €13324EUR$14,995USD£11,537GBP
- Report
- February 2025
- 84 Pages
Global
From €8881EUR$9,995USD£7,690GBP
- Report
- January 2025
- 164 Pages
Global
From €13324EUR$14,995USD£11,537GBP
- Clinical Trials
- January 2025
- 47 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Clinical Trials
- January 2025
- 108 Pages
Global
From €3066EUR$3,450USD£2,654GBP
- Clinical Trials
- January 2025
- 615 Pages
Global
From €3066EUR$3,450USD£2,654GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more